Imagenetix, Inc. (IAGX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
+0.000199 (19,900.00%)
At close: May 19, 2026
Imagenetix Revenue
Imagenetix had revenue of $377.52K in the quarter ending June 30, 2015, a decrease of -30.75%.
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
5.72K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2015 | - | - | - |
| Mar 31, 2011 | 7.13M | 532.78K | 8.08% |
| Mar 31, 2010 | 6.60M | -864.80K | -11.59% |
| Mar 31, 2009 | 7.46M | 1.89M | 33.96% |
| Mar 31, 2008 | 5.57M | -27.13K | -0.48% |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aida Pharmaceuticals | 40.51M |
| GSRX Industries | 10.13M |
| Bloomios | 8.23M |
| Creative Edge Nutrition | 3.80M |
| Global Roundtable | 1.24M |
| CuraScientific | 1.05M |
| CEN Biotech | 1.03M |
| Opus Holdings | 758.68K |